Dr. Purushothama Chary Khandavalli

Angestellt, Corporate Drug Regulatory Affairs Manager, MEDA Pharma GmbH & Co. KG (A VIATRIS Company)
Bad Homburg vor der Höhe, Germany

Fähigkeiten und Kenntnisse

Expertise in multi-step Natural Product Synthesis
Project Management
API
MS Office
Drug Development
Due Diligence
Project Leadership
Drug Master File Assessment
Drug Regulatory Affairs CMC
Product-Life-Cycle Management
Subject Matter Expert API Starting Materials
Extensive experience of QSAR based New Chemical En
Strategic mindset
International experience
Intercultural competence
Leadership skills

Werdegang

Berufserfahrung von Purushothama Chary Khandavalli

  • Current 3 years and 2 months, since Apr 2023

    Corporate Drug Regulatory Affairs Manager

    MEDA Pharma GmbH & Co. KG (A VIATRIS Company)

  • 1 year and 3 months, Jan 2022 - Mar 2023

    Project Manager Regulatory Interfaces, Quality Unit

    Salutas Pharma GmbH / Novartis Technical Operations

  • 8 years, Jan 2014 - Dec 2021

    Manager Global Drug Regulatory Affairs MRC

    Salutas Pharma GmbH / Novartis Technical Operations

  • 10 months, Dec 2012 - Sep 2013

    Senior Research Scientist

    MOLISA GmbH

    Synthesis of API impurities - Desfluorinated Nebivolol Isomers. Experience in negotiations with third party alliances (TPA) for strategic outsourcing and venture capital investment business plans.

  • 8 years and 7 months, Oct 2003 - Apr 2012

    Senior Research Scientist

    MOLISA GmbH

    Professional on hands expertise in natural product synthesis, heterocyclic chemistry, peptide chemistry, quality structure-activity based drug design (QSAR), hit to lead synthesis and process development of new chemical entities (NCE), APIs for renowned chemical and pharma industries.

Ausbildung von Purushothama Chary Khandavalli

  • 1 year and 2 months, Aug 2002 - Sep 2003

    Schering Postdoctoral Research Fellowship

    Freie Universität Berlin

    Prof. Dr. Markus Kalesse Research Group: Scale-up process - Total synthesis of (+)-Ratjadone, involving 24 convergent synthetic steps for pre-clinical studies supporting a collaborative drug discovery project with Schering AG (now Bayer AG), Berlin, Germany. First total synthesis of Leptolstatin. Prof. Dr. Hans-Ulrich Reissig Research Group: Developed new synthesis of Trifluoromethyl Substituted Pyridinols – interesting building blocks for potential biological active compounds.

  • 1 year and 11 months, Sep 2000 - Jul 2002

    Postdoctoral Research (Natural Products Synthesis)

    Leibniz Universität Hannover

    Prof. Dr. Markus Kalesse Research Group: Natural Product Synthesis: Successful Synthesis of Ratjadone derivatives, (-)-Callystatin A.

  • 5 years and 8 months, Nov 1994 - Jun 2000

    Organic Chemistry

    Indian Institute of Chemical Technology (Osmania University), Hyderabad, India

    Non-Carbohydrate Nucleosides, Oxazolo-Benzimidazoles Synthesis and Pesticide Activity, New Methodologies based on Modified Borohydrides

  • 1 year and 2 months, Jul 1993 - Aug 1994

    Chemistry

    University of Hyderabad, India

    Advanced Physical, Inorganic and Organic Chemistry

  • 2 years and 2 months, Apr 1990 - May 1992

    Chemistry

    National Institute of Technology, Kakatiya University, Warangal, India

    Drugs, Dyes, Pharmaceuticals and Pesticides

Sprachen

  • English

    C1 (Fließend)

  • German

    B1-B2 (Gute Kenntnisse)

  • Hindi

    C1 (Fließend)

  • Telugu

    C1 (Fließend)

XING – Das Jobs-Netzwerk

  • Über eine Million Jobs

    Entdecke mit XING genau den Job, der wirklich zu Dir passt.

  • Persönliche Job-Angebote

    Lass Dich finden von Arbeitgebern und über 20.000 Recruiter·innen.

  • 21 Mio. Mitglieder

    Knüpf neue Kontakte und erhalte Impulse für ein besseres Job-Leben.

  • Kostenlos profitieren

    Schon als Basis-Mitglied kannst Du Deine Job-Suche deutlich optimieren.

21 Mio. XING Mitglieder, von A bis Z